Published in:
01-11-2017 | Erratum
Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
Published in: Breast Cancer Research and Treatment | Issue 1/2017
Login to get accessExcerpt
The text in panel B of Fig. 1 (progression-free survival for patients with stable, treated brain metastases) was incorrectly labeled as mOS instead of mPFS. All other values and labels are correct. The corrected Figure 1 is given in this erratum.
Fig. 1
Kaplan–Meier estimates for a overall survival and b progression-free survival for patients with stable, treated brain metastases; and c overall survival for patients with radiologically detectable, but stable, brain lesions at study entry. CI confidence interval, HR hazard ratio, mOS median overall survival, mPFS median progression-free survival, TPC treatment of physician’s choice
× ![]()
…